Kobe City Medical Center General Hospital
Kobe, Hyogo, Japan
Government hospital in Kobe
〒650-0047 Hyogo, Kobe, Chuo Ward, Minatojima Minamimachi, 2 Chome−１−1
About Kobe City Medical Center General Hospital
"当院は、768床の病床、30を超える診療科を有する神戸市域の基幹病院です。24時間365日市民の生命と健康を守る「最後の砦」としての役割を果たし続けていくとともに、癒しと安らぎの環境をあわせ持つ、21世紀にふさわしい病院を目指します。"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kobe City Medical Center General Hospital
During the past decade, Kobe City Medical Center General Hospital conducted 103 clinical trials. In the 10-year time frame, 103 clinical trials started and 56 clinical trials were completed, i.e. on
average, 54.4% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 28 clinical trials were completed. i.e. 70%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
2013-12-13
Active, not recruiting
1,473
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
2013-12-23
2023-07-01
Active, not recruiting
488
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kobe City Medical Center General Hospital" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Janssen Research & Development, LLC" with 13 trials
sponsored, "Pfizer" with 12 trials sponsored, "Bayer" with 8 trials sponsored and "Boehringer Ingelheim"
with 8 trials sponsored. Other sponsors include 98 different institutions and
companies that sponsored additional 59 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kobe City Medical Center General Hospital"
#1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "Kobe City General Hospital" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were
collaborators in the rest 58 trials.
Clinical Trials Conditions at Kobe City Medical Center General Hospital
According to Clinical.Site data, the most researched conditions in "Kobe City Medical Center General Hospital" are
"Multiple Myeloma" (8 trials), "Alzheimer Disease" (5 trials), "Atrial Fibrillation" (5 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials) and "Acute Ischemic Stroke" (4 trials). Many other conditions were trialed in "Kobe City Medical Center General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kobe City Medical Center General Hospital
Most popular intervention types in "Kobe City Medical Center General Hospital" are "Drug" (128 trials), "Device" (9 trials), "Other" (9 trials), "Biological" (8 trials) and "Procedure" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (29 trials), "Rituximab" (9 trials), "Carboplatin" (8 trials), "Paclitaxel" (8 trials) and "Docetaxel" (7 trials). Other intervention names were less common.
Clinical Trials Genders at Kobe City Medical Center General Hospital
The vast majority of trials in "Kobe City Medical Center General Hospital" are
145 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at Kobe City Medical Center General Hospital
Currently, there are NaN active trials in "Kobe City Medical Center General Hospital".
undefined are not yet recruiting,
33 are recruiting,
27 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 76 completed trials in Kobe City Medical Center General Hospital,
undefined suspended trials,
and 11 terminated clinical trials to date.
Out of the total trials that were conducted in Kobe City Medical Center General Hospital, 9 "Phase 1"
clinical trials were conducted, 35 "Phase 2" clinical
trials and 91 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 10 trials that are defined as “Not Applicable".